Latham & Watkins represented Icosavax, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its...
Icosavax’s $209.3 Million IPO
LegalZoom’s Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering. LegalZoom.com, Inc., a leading online platform for legal and compliance solutions in the United States, has...
Janux Therapeutics’ $193.8 Million IPO
Wilson Sonsini Goodrich & Rosati advised Janux Therapeutics, Inc. on the deal, while Latham & Watkins LLP represented the underwriters. Janux Therapeutics, Inc., a biopharmaceutical company...
Bright Machines’ Merger with SCVX
Willkie Farr & Gallagher LLP represented SCVX in the transaction, while Latham & Watkins LLP and Wolf Theiss represented Bright Machines. SCVX (NYSE: SCVX), a special...